Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Grasedieck

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Blood|April 4, 2013
Circulating microRNAs in hematological diseases: principles, challenges, and perspectivesSarah Grasedieck, Antonio Sorrentino, Christian Langer, et al.
Leukemia|October 17, 2023
Identification of multivariable microRNA and clinical biomarker panels to predict imatinib response in chronic myeloid leukemia at diagnosisAndrew Wu, Ryan Yen, Sarah Grasedieck, et al.
Oncotarget|December 30, 2016
Prospective identification of resistance mechanisms to HSP90 inhibition in KRAS mutant cancer cellsArefeh Rouhi, Christina Miller, Sarah Grasedieck, et al.
Leukemia|August 23, 2022
Identification of key microRNAs as predictive biomarkers of Nilotinib response in chronic myeloid leukemia: a sub-analysis of the ENESTxtnd clinical trialRyan Yen, Sarah Grasedieck, Andrew Wu, et al.
Haematologica|December 2, 2021
The retinoic acid receptor co-factor NRIP1 is uniquely upregulated and represents a therapeutic target in acute myeloid leukemia with chromosome 3q rearrangementsSarah Grasedieck, Ariene Cabantog, Liam MacPhee, et al.
Haematologica|October 4, 2017
Circular RNAs of the nucleophosmin (NPM1) gene in acute myeloid leukemiaSusanne Hirsch, Tamara J Blätte, Sarah Grasedieck, et al.
Leukemia|March 18, 2025
The proto-oncogenic miR-106a-363 cluster enhances adverse risk acute myeloid leukemia through mitochondrial activationNadine Sperb, Irina A Maksakova, Leo Escano, et al.
Blood|March 31, 2021
Targeting AXL kinase sensitizes leukemic stem and progenitor cells to venetoclax treatment in acute myeloid leukemiaXiaojia Niu, Katharina Rothe, Min Chen, et al.
Nature Communications|August 11, 2017
The non-coding RNA landscape of human hematopoiesis and leukemiaAdrian Schwarzer, Stephan Emmrich, Franziska Schmidt, et al.
Leukemia|November 27, 2019
MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cellsEdith Schneider, Nicole Pochert, Christoph Ruess, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Blood|April 4, 2013
Circulating microRNAs in hematological diseases: principles, challenges, and perspectivesSarah Grasedieck, Antonio Sorrentino, Christian Langer, et al.
Leukemia|October 17, 2023
Identification of multivariable microRNA and clinical biomarker panels to predict imatinib response in chronic myeloid leukemia at diagnosisAndrew Wu, Ryan Yen, Sarah Grasedieck, et al.
Oncotarget|December 30, 2016
Prospective identification of resistance mechanisms to HSP90 inhibition in KRAS mutant cancer cellsArefeh Rouhi, Christina Miller, Sarah Grasedieck, et al.
Leukemia|August 23, 2022
Identification of key microRNAs as predictive biomarkers of Nilotinib response in chronic myeloid leukemia: a sub-analysis of the ENESTxtnd clinical trialRyan Yen, Sarah Grasedieck, Andrew Wu, et al.
Haematologica|December 2, 2021
The retinoic acid receptor co-factor NRIP1 is uniquely upregulated and represents a therapeutic target in acute myeloid leukemia with chromosome 3q rearrangementsSarah Grasedieck, Ariene Cabantog, Liam MacPhee, et al.
Haematologica|October 4, 2017
Circular RNAs of the nucleophosmin (NPM1) gene in acute myeloid leukemiaSusanne Hirsch, Tamara J Blätte, Sarah Grasedieck, et al.
Leukemia|March 18, 2025
The proto-oncogenic miR-106a-363 cluster enhances adverse risk acute myeloid leukemia through mitochondrial activationNadine Sperb, Irina A Maksakova, Leo Escano, et al.
Blood|March 31, 2021
Targeting AXL kinase sensitizes leukemic stem and progenitor cells to venetoclax treatment in acute myeloid leukemiaXiaojia Niu, Katharina Rothe, Min Chen, et al.
Nature Communications|August 11, 2017
The non-coding RNA landscape of human hematopoiesis and leukemiaAdrian Schwarzer, Stephan Emmrich, Franziska Schmidt, et al.
Leukemia|November 27, 2019
MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cellsEdith Schneider, Nicole Pochert, Christoph Ruess, et al.
Pageof 1